Abstract
Tyrosinemia type II is an inborn error of metabolism caused by a mutation in a gene encoding the enzyme tyrosine aminotransferase leading to an accumulation of tyrosine in the body, and is associated with neurologic and development difficulties in numerous patients. Because the accumulation of tyrosine promotes oxidative stress and DNA damage, the main aim of this study was to investigate the possible antioxidant and neuroprotective effects of omega-3 treatment in a chemically-induced model of Tyrosinemia type II in hippocampus, striatum and cerebral cortex of rats. Our results showed chronic administration of L-tyrosine increased the frequency and the index of DNA damage, as well as the 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels in the hippocampus, striatum and cerebral cortex. Moreover, omega-3 fatty acid treatment totally prevented increased DNA damage in the striatum and hippocampus, and partially prevented in the cerebral cortex, whereas the increase in 8-OHdG levels was totally prevented by omega-3 fatty acid treatment in hippocampus, striatum and cerebral cortex. In conclusion, the present study demonstrated that the main accumulating metabolite in Tyrosinemia type II induce DNA damage in hippocampus, striatum and cerebral cortex, possibly mediated by free radical production, and the supplementation with omega-3 fatty acids was able to prevent this damage, suggesting that could be involved in the prevention of oxidative damage to DNA in this disease. Thus, omega-3 fatty acids supplementation to Tyrosinemia type II patients may represent a new therapeutic approach and a possible adjuvant to the curren t treatment of this disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arunagiri P, Rajeshwaran K, Shanthakumar J, Tamilselvan T, Balamurugan E (2014) Combination of omega-3 fatty acids, lithium, and aripiprazole reduces oxidative stress in brain of mice with mania. Biol Trace Elem Res 160:409–417. doi:10.1007/s12011-014-0067-8
Bazan NG (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 15:159–166
Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B (2007) Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr 150:479–484. doi:10.1016/j.jpeds.2006.12.011
Beckman KB, Ames BN (1997) Oxidative decay of DNA. J Biol Chem 272:19633–19636
Brea D, Roquer J, Serena J, Segura T, Castillo J, Artico S (2012) Oxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins. BMC Neurol 12:65. doi:10.1186/1471-2377-12-65
Chandrasekar B, Fernandes G (1994) Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis. Biochem Biophys Res Commun 200:893–898. doi:10.1006/bbrc.1994.1534
Collins AR (2004) The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26:249–261. doi:10.1385/MB:26:3:249
Collins AR et al (2008) The comet assay: topical issues. Mutagenesis 23:143–151. doi:10.1093/mutage/gem051
de Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2011) Tyrosine inhibits creatine kinase activity in cerebral cortex of young rats. Metab Brain Dis 26:221–227. doi:10.1007/s11011-011-9255-9
de Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2012) Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats. Mol Cell Biochem 364:253–261. doi:10.1007/s11010-012-1225-y
de Andrade RB et al (2015) Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats. Mol Neurobiol 51:1184–1194. doi:10.1007/s12035-014-8791-9
De Pra SD et al (2014) L-tyrosine induces DNA damage in brain and blood of rats. Neurochem Res 39:202–207. doi:10.1007/s11064-013-1207-9
El-Khamisy SF, Caldecott KW (2006) TDP1-dependent DNA single-strand break repair and neurodegeneration. Mutagenesis 21:219–224. doi:10.1093/mutage/gel024
Ferreira GK et al (2012) L-tyrosine administration increases acetylcholinesterase activity in rats. Neurochem Int 61:1370–1374. doi:10.1016/j.neuint.2012.09.017
Ferreira GK et al (2013a) Effect of acute and chronic administration of L-tyrosine on nerve growth factor levels in rat brain. Neurochem Res 38:1742–1746. doi:10.1007/s11064-013-1078-0
Ferreira GK et al (2013b) Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats. Neurotox Res 23:327–335. doi:10.1007/s12640-012-9345-4
Ferreira GK et al (2014) An evaluation of the effects of acute and chronic L-tyrosine administration on BDNF levels and BDNF mRNA expression in the rat brain. Mol Neurobiol 49:734–740. doi:10.1007/s12035-013-8552-1
Ferreira GK et al (2015) The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility. Metab Brain Dis 30:215–221. doi:10.1007/s11011-014-9615-3
Fraser NG, MacDonald J, Griffiths WA, McPhie JL (1987) Tyrosinaemia type II (Richner-Hanhart syndrome)--report of two cases treated with etretinate. Clin Exp Dermatol 12:440–443
Gil-Campos M, Sanjurjo Crespo P (2012) Omega 3 fatty acids and inborn errors of metabolism. Br J Nutr 107(Suppl 2):S129–S136. doi:10.1017/S0007114512001523
Goldsmith LA (1978) Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome). Experimental cell biology 46:96–113
Goldsmith LA, Kang E, Bienfang DC, Jimbow K, Gerald P, Baden HP (1973) Tyrosinemia with plantar and palmar keratosis and keratitis. J Pediatr 83:798–805
Halliwell B (2007) Biochemistry of oxidative stress. Biochem Soc Trans 35:1147–1150. doi:10.1042/BST0351147
Held PK (2006) Disorders of tyrosine catabolism. Mol Genet Metab 88:103–106
Huxley RR, Neil HA (2003) The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr 57:904–908. doi:10.1038/sj.ejcn.1601624
Jain S, Gaiha M, Bhattacharjee J, Anuradha S (2002) Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study. J Assoc Physicians India 50:1028–1033
Katsumata T, Katayama Y, Obo R, Muramatsu H, Ohtori T, Terashi A (1999) Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. Eur J Pharmacol 372:167–174
Kaur P, Heggland I, Aschner M, Syversen T (2008) Docosahexaenoic acid may act as a neuroprotector for methylmercury-induced neurotoxicity in primary neural cell cultures. Neurotoxicology 29:978–987. doi:10.1016/j.neuro.2008.06.004
Kesavulu MM, Kameswararao B, Apparao C, Kumar EG, Harinarayan CV (2002) Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes & metabolism 28:20–26
Kitajka K, Puskas LG, Zvara A, Hackler L Jr, Barcelo-Coblijn G, Yeo YK, Farkas T (2002) The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci U S A 99:2619–2624. doi:10.1073/pnas.042698699
Kroger E et al (2009) Omega-3 fatty acids and risk of dementia: the Canadian study of health and aging. Am J Clin Nutr 90:184–192. doi:10.3945/ajcn.2008.26987
Lindahl T (1993) Instability and decay of the primary structure of DNA. Nature 362:709–715. doi:10.1038/362709a0
Macedo LG et al (2013) Effect of acute administration of L-tyrosine on oxidative stress parameters in brain of young rats. Neurochem Res 38:2625–2630. doi:10.1007/s11064-013-1180-3
Macsai MS, Schwartz TL, Hinkle D, Hummel MB, Mulhern MG, Rootman D (2001) Tyrosinemia type II: nine cases of ocular signs and symptoms. Am J Ophthalmol 132:522–527
Mahadik SP, Evans D, Lal H (2001) Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 25:463–493
Martin LJ (2008) DNA damage and repair: relevance to mechanisms of neurodegeneration. J Neuropathol Exp Neurol 67:377–387. doi:10.1097/NEN.0b013e31816ff780
Mazer LM, Yi SH, Singh RH (2010) Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease. J Inherit Metab Dis 33:121–127. doi:10.1007/s10545-010-9066-x
McAnulty SR et al (2010) Effect of n-3 fatty acids and antioxidants on oxidative stress after exercise. Med Sci Sports Exerc 42:1704–1711. doi:10.1249/MSS.0b013e3181d85bd1
Mitchell GA, Grompe M, Lambert M, Tanguay RM (2001) Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, vol 8. Mc Graw-Hill, New York, pp 1977–1982
Nishida N et al (2013) Reactive oxygen species induce epigenetic instability through the formation of 8-hydroxydeoxyguanosine in human hepatocarcinogenesis. Dig Dis 31:459–466. doi:10.1159/000355245
Paker AM et al (2010) Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial. Neurology 75:826–830. doi:10.1212/WNL.0b013e3181f07061
Powell CL, Swenberg JA, Rusyn I (2005) Expression of base excision DNA repair genes as a biomarker of oxidative DNA damage. Cancer Lett 229:1–11. doi:10.1016/j.canlet.2004.12.002
Ramos AC et al (2013) Acute administration of l-tyrosine alters energetic metabolism of hippocampus and striatum of infant rats. Int J Dev Neurosci 31:303–307. doi:10.1016/j.ijdevneu.2013.03.005
Rao KS (1993) Genomic damage and its repair in young and aging brain. Mol Neurobiol 7:23–48
Raza Y et al (2014) Oxidative DNA damage as a potential early biomarker of helicobacter pylori associated carcinogenesis. Pathology oncology research : POR 20:839–846. doi:10.1007/s12253-014-9762-1
Salamon T et al (1988) [4 cases of Richner-Hanhart syndrome (tyrosinemia type II) with neurological symptomatology in a Yugoslav family]. Der Hautarzt. Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 39:149–154
Samieri C et al (2008) Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr 88:714–721
Sayar RB, von Domarus D, Schafer HJ, Beckenkamp G (1988) Clinical picture and problems of keratoplasty in Richner-Hanhart syndrome (tyrosinemia type II). Ophthalmologica Journal International D'ophtalmologie International Journal of Ophthalmology Zeitschrift fur Augenheilkunde 197:1–6
Scaini G et al (2012) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106:169–174. doi:10.1016/j.ymgme.2012.04.009
Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt JP (2012) Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men. Nutrition & metabolism 9:45. doi:10.1186/1743-7075-9-45
Scott CR (2006) The genetic tyrosinemias. Am J Med Genet C: Semin Med Genet 142C:121–126. doi:10.1002/ajmg.c.30092
Sener RN (2005) Tyrosinemia: computed tomography, magnetic resonance imaging, diffusion magnetic resonance imaging, and proton spectroscopy findings in the brain. J Comput Assist Tomogr 29:323–325
Sgaravatti AM et al (2008) Tyrosine promotes oxidative stress in cerebral cortex of young rats. Int J Dev Neurosci 26:551–559. doi:10.1016/j.ijdevneu.2008.05.007
Sgaravatti AM et al (2009) Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex. Metab Brain Dis 24:415–425. doi:10.1007/s11011-009-9153-6
Shakeri J et al (2016) Effects of omega-3 supplement in the treatment of patients with bipolar I disorder. Int J Prev Med 7:77. doi:10.4103/2008-7802.182734
Simon KR et al (2013) DNA damage induced by phenylalanine and its analogue p-chlorophenylalanine in blood and brain of rats subjected to a model of hyperphenylalaninemia. Biochem Cell Biol = Biochimie et Biologie Cellulaire 91:319–324. doi:10.1139/bcb-2013-0023
Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191
Sitta A et al (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21:287–296. doi:10.1007/s11011-006-9035-0
Spector AA (1999) Essentiality of fatty acids. Lipids 34(Suppl):S1–S3
Speit G, Hartmann A (2005) The comet assay: a sensitive genotoxicity test for the detection of DNA damage. Methods Mol Biol 291:85–95
Speit G, Rothfuss A (2012) The comet assay: a sensitive genotoxicity test for the detection of DNA damage and repair. Methods Mol Biol 920:79–90. doi:10.1007/978-1-61779-998-3_6
Tice RR et al (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221
Vlaardingerbroek H, Hornstra G, de Koning TJ, Smeitink JA, Bakker HD, de Klerk HB, Rubio-Gozalbo ME (2006) Essential polyunsaturated fatty acids in plasma and erythrocytes of children with inborn errors of amino acid metabolism. Mol Genet Metab 88:159–165. doi:10.1016/j.ymgme.2006.01.012
Walz CP, Barry AR, Koshman SL (2016) Omega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease. Can Pharm J: CPJ = revue des pharmaciens du Canada : RPC 149:166-173 doi:10.1177/1715163516640812
Yavin E, Brand A, Green P (2002) Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr Neurosci 5:149–157. doi:10.1080/10284150290003159
Young G, Conquer J (2005) Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 45:1–28
Acknowledgements
This research was supported by grants from Programa de Pós-graduação em Ciências da Saúde – Universidade do Extremo Sul Catarinense (UNESC) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carvalho-Silva, M., Gomes, L.M., Scaini, G. et al. Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II. Metab Brain Dis 32, 1043–1050 (2017). https://doi.org/10.1007/s11011-017-9994-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-017-9994-3